Eileen E. Navarro-Almario

Infectious Disease

50 Irving Street Nw.
Washington, DC 20422

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 6 publications

R Value-Based Criteria Outperform Alkaline Phosphatase Less than Twice Normal in Identifying Hy's Law Cases in Clinical Trials.

R Value-Based Criteria Outperform Alkaline Phosphatase Less than Twice Normal in Identifying Hy's Law Cases in Clinical Trials.

Journal: Drug safety

Published: May 12, 2025

Emerging Tools to Support DILI Assessment in Clinical Trials with Abnormal Baseline Serum Liver Tests or Pre-existing Liver Diseases.

Emerging Tools to Support DILI Assessment in Clinical Trials with Abnormal Baseline Serum Liver Tests or Pre-existing Liver Diseases.

Journal: Drug safety

Published: December 11, 2024

Navigating the Future: Considerations for use of Continuous Glucose Monitoring in Diabetes Trials.

Navigating the Future: Considerations for use of Continuous Glucose Monitoring in Diabetes Trials.

Journal: Therapeutic innovation & regulatory science

Published: October 03, 2024

Composite Plot for Visualizing Aminotransferase and Bilirubin Changes in Clinical Trials of Subjects with Abnormal Baseline Values.

Composite Plot for Visualizing Aminotransferase and Bilirubin Changes in Clinical Trials of Subjects with Abnormal Baseline Values.

Journal: Drug safety

Published: March 17, 2024

Global Standards to Expedite Learning From Medical Research Data.

Global Standards to Expedite Learning From Medical Research Data.

Journal: Clinical and translational science

Published: February 20, 2018

Review article: therapeutic bile acids and the risks for hepatotoxicity.

Review article: therapeutic bile acids and the risks for hepatotoxicity.

Journal: Alimentary pharmacology & therapeutics

Published: January 15, 2018

Showing 1-6 of 6

Last Updated: 09/26/2026